Chondrometrics GmbH announced today that ArthroVision Inc., a wholly-owned subsidiary of Horizon Sciences & Technologies Inc., Montreal, has accepted the decision of the District Court of Munich, Germany from March 19^th 2009 that Chondrometrics GmbH does not make use of the claims of ArthroVision's patent EP 1 230 561 and therefore does not infringe on the German part of the patent. ArthroVision has withdrawn its appeal for the first instance judgment to be taken to the 2^nd level of jurisdiction and thus accepts the decision as being final.

Montreal based ArthroVision Inc. has also abandoned the German part of the Osteoarthritis research related European patent EP 1 230 561 (Title: Evaluating Disease Progression using Magnetic Resonance Imaging) and waived all claims against Chondrometrics GmbH based on this patent for the past, in view of an invalidity complaint filed by Chondrometrics GmbH in the German Federal Patent Court of Munich.

About Chondrometrics GmbH

Chondrometrics GmbH, a Germany-based company located in Ainring, Bavaria, is a leading provider of medical image analysis services to researchers in academia and in the pharmaceutical industry. The focus of the company is on quantitative analysis of articular cartilage from magnetic resonance images (MRI) and on the research of osteoarthritis. The company has developed a highly efficient software platform and formed a team of specialized and highly experienced readers to provide quantitative imaging surrogates of tissue adaptation and disease progression for large scale studies. Representatives of the company have published extensively in the biomedical literature, with the aims of providing novel and more efficient image analysis methodologies, and to gain a better understanding of musculoskeletal diseases, specifically osteoarthritis. For more information about Chondrometrics GmbH, please visit www.chondrometrics.com